Bacil Pharma Ltd — Important, 27-08-2025: Company Update

Bacil Pharma's board has approved key appointments to strengthen its governance and oversight. M/s Sarang Shivajirao Chavan & Associates has been appointed as the new Statutory Auditor for the financial year 2025-2026, enhancing financial transparency. Additionally, Mr. Vivek Mukesh Yadav has joined as an Independent Director. Mr. Yadav brings valuable expertise in finance, accounts, and corporate management, with significant experience in financial planning and regulatory compliance, which is expected to support the company's financial and operational strategy.